Literature DB >> 27668230

Mitral valve replacement in a dialysis-dependent patient.

Ansheng Mo1, Zhihu Tao2, Zhiqiang Feng1, Xiaoping Yang1, Jun Wu1.   

Abstract

Patients with end-stage renal disease have a higher risk of morbidity and mortality than those without end-stage renal disease in cardiovascular surgery. Poor outcomes are especially found in patients who undergo valve surgery. We report successful mitral valve replacement (MVR) in a dialysis-dependent patient. The patient recovered well at postoperation and had the complication of anticoagulation at follow-up. Based on this successful case, we believe that myocardial protection, prevention of infection, nutritional support, and close monitoring of blood coagulation function are important in dialysis-dependent patients undergoing valve replacement.

Entities:  

Keywords:  Dialysis; end-stage renal disease; valve replacement

Year:  2016        PMID: 27668230      PMCID: PMC5009039          DOI: 10.21037/atm.2016.08.02

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  22 in total

Review 1.  Platelet dysfunction and end-stage renal disease.

Authors:  Dinkar Kaw; Deepak Malhotra
Journal:  Semin Dial       Date:  2006 Jul-Aug       Impact factor: 3.455

2.  Hemorrhage as a life-threatening complication after valve replacement in end-stage renal disease patients.

Authors:  Taro Nakatsu; Nobushige Tamura; Shigeki Yanagi; Shoichi Kyo; Takaaki Koshiji; Ryuzo Sakata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-04-19

3.  Long-term survival for patients with preoperative renal failure undergoing bioprosthetic or mechanical valve replacement.

Authors:  Vinod H Thourani; Eric L Sarin; W Brent Keeling; Patrick D Kilgo; Robert A Guyton; Ameesh B Dara; John D Puskas; Edward P Chen; William A Cooper; J David Vega; Cullen D Morris; Omar M Lattouf
Journal:  Ann Thorac Surg       Date:  2011-02-25       Impact factor: 4.330

4.  Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?

Authors:  J H S You; F W H Chan; R S M Wong; G Cheng
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

5.  Low-intensity international normalized ratio (INR) oral anticoagulant therapy in Chinese patients with mechanical heart valve prostheses.

Authors:  Zhang Haibo; Li Jinzhong; Liu Yan; Meng Xu
Journal:  Cell Biochem Biophys       Date:  2012-01       Impact factor: 2.194

6.  Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS.

Authors:  Manish M Sood; Maria Larkina; Jyothi R Thumma; Francesca Tentori; Brenda W Gillespie; Shunichi Fukuhara; David C Mendelssohn; Kevin Chan; Patricia de Sequera; Paul Komenda; Claudio Rigatto; Bruce M Robinson
Journal:  Kidney Int       Date:  2013-05-15       Impact factor: 10.612

7.  Warfarin dosage adjustment strategy in Chinese population.

Authors:  Zhe Yu; Ying-Long Ding; Fei Lu; Li-Yan Miao; Zhen-Ya Shen; Wen-Xue Ye
Journal:  Int J Clin Exp Med       Date:  2015-06-15

8.  [Peri-operative management and follow-up outcomes of cardiac surgery in dialysis-dependent patients with end stage renal disease].

Authors:  Xi-hui Li; Yan Li; Feng Xiao; Yi-fan Li; Jin Wang; Bo Song; Yang Yang; Shi-yong Dong
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2013-08-18

Review 9.  Nutrition prescription to achieve positive outcomes in chronic kidney disease: a systematic review.

Authors:  Susan Ash; Katrina L Campbell; Jessica Bogard; Anna Millichamp
Journal:  Nutrients       Date:  2014-01-22       Impact factor: 5.717

10.  Warfarin dosage response related pharmacogenetics in Chinese population.

Authors:  Siyue Li; Yuangao Zou; Xia Wang; Xunbei Huang; Yong Sun; Yuqing Wang; Li Dong; Hong Jiang
Journal:  PLoS One       Date:  2015-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.